AEVI GENOMIC Cash Flow - Quarterly (NASDAQ:GNMX)

Add to My Stocks
$1.2 $0.06 (5.26%) GNMX stock closing price Jun 22, 2018 (Closing)

The cash flow statement is one of the reports a publicly traded company like AEVI GENOMIC needs to disclose. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about AEVI GENOMIC profits and AEVI GENOMIC debt. AEVI GENOMIC saw a cash impact of $- from the buyback of GNMX shares. The cash flow statement helps in the AEVI GENOMIC stock analysis by providing more information for evaluating changes in assets, liabilities and equities. AEVI GENOMIC saw a outflow of $- from investing activities till 2018 Q1.

View and download details of AEVI GENOMIC cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
-8.7M-34.71M-27.55M-18.95M-10.91M-41.9M-33.42M-22.85M-11.14M-37.99M
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities--2.04M-0.12M-1.4M-0.77M2.09M1.73M-0.47M-0.42M-0.1M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net-3.4M2.68M1.77M1M6.78M6.18M4.26M2.4M13.5M
Net Cash from (used by) Operating Activities
-7.24M-33.24M-24.9M-18.5M-10.65M-32.74M-25.27M-18.93M-9.1M-24.34M
Increase (Decrease) in Prop Plant And Equipment------0.22M-0.26M-0.19M-0.06M-0.18M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
------0.22M-0.26M-0.19M-0.06M-0.18M
Issuance (Purchase) of Equity Shares-26.98M---19.74M19.72M19.75M-44.31M
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities---0.14M-------
Net Cash from (used by) Financing Activities
-26.98M-0.12M--19.74M19.72M19.75M-44.31M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-7.2M-6.1M-24.87M-18.48M-10.63M-13.22M-5.8M--9.17M19.77M
Cash & Equivalents at Beginning of Year39.83M53.06M33.28M22.39M6.43M4.99M2.85M---
Cash & Equivalents at Year End26.52M33.72M14.96M21.35M29.2M39.83M47.25M53.68M43.89M53.06M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The AEVI GENOMIC stock price history and AEVI GENOMIC stock comparison chart inevitably reflect its cash flow situation.

  • AEVI GENOMIC had a Net Change in Cash and Cash Equivalents of $-7.2M in the latest quarter 2018 Q1. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the AEVI GENOMIC stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. AEVI GENOMIC lost $-7.24M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: AEVI GENOMIC used $- cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $- for AEVI GENOMIC.

Key Financial Ratios For AEVI GENOMIC Cash Flow